We’re delighted to appoint Saswati Saha Mitra, Jo Paice and Angie Ma to the board leadership team to drive forward progress for those with ovarian cancer.
Saswati Saha Mitra, Jo Paice and Angie Ma bring a broad range of specialist skills and knowledge which will accelerate us towards our ambition of transforming diagnosis, access to treatment and care of women with ovarian cancer and stopping the disease from devastating lives.
Saswati Saha Mitra
Saswati Saha Mitra will bring her passion for global inclusion to the role at Target Ovarian Cancer. As Director of Research at WhatsApp, she has expertise in using technology to better connect and serve large populations though innovation. Around 7,500 women are diagnosed with ovarian cancer in the UK every year, and Saswati’s experience will help us to reach and further connect women through our supportive services.
Saswati said:
Target Ovarian Cancer is an aspirational organisation which has built an incredible online community for those affected by the disease, under the inspiring leadership of Annwen Jones. As an incoming trustee, I hope to bring my expertise in cutting edge consumer technologies and best practices in online productivity and community building. I hope that this will enable Target Ovarian Cancer to serve its community as best as it possibly can, while fostering and continuing to build on the deep, human connection established.
Jo Paice
Clinics Director, Jo Paice, has worked at Bupa Health Clincs for 20 years where formerly she was Finance Director, having qualified as a chartered accountant at Deloitte. Bupa Health Clinics specialise in wellbeing services, such as health assessments, along with primary care through GP appointments, menopause and period plans, physiotherapy and mental health services.
One of our key focus areas is supporting primary care professionals with education and training to diagnose ovarian cancer as early as possible, and Jo hopes to use her expertise in both finance and the healthcare industry to help the charity achieve its ultimate goal – to save more lives.
Jo said:
On a personal level, I lost my Aunt Sheila to ovarian cancer some years ago and I want to help change the future for women affected by this disease. Cancer features very heavily in my role and I hear so many stories from patients who have had cancer detected, and know there is more that can be done for ovarian cancer. The opportunity to work closely with Target Ovarian Cancer to find solutions to many issues those living with ovarian cancer face was one that couldn’t be overlooked.
Angie Ma
Angie Ma, a physicist by training, brings nearly two decades of experience in science and technology to the forefront. She co-founded Faculty: Europe’s leading applied AI firm and a world leader in AI safety and responsible AI deployment.
Angie is well-versed in navigating the intricacies of technology’s role in driving impact and achieving strategic goals for organisations, and will utilise these skills to harness new opportunities in the ever-changing digital landscape to support women with ovarian cancer. Driven by a deep commitment to philanthropy and to maximise impact, Angie joins Target Ovarian Cancer to support a cause that holds personal significance.
Angie said:
I hope to forge stronger connections with the technology sector to garner support for Target Ovarian Cancer. Having worked on transforming organisational performance through safe, impactful and human-first AI in the past decade, I’m committed to providing valuable insights to advise and help inform the charity’s digital strategy, ensuring it aligns with the organisation's strategic goals.
Saswati, Jo and Angie were appointed on Thursday 29 February, alongside Bank of England General Counsel Sonya Branch as Chair of the Board of Trustees. We're very grateful to have received excellent pro-bono support from executive search and talent agency The MBS Group to recruit Saswati, Jo and Angie.
Sonya Branch, Chair of the Board of Trustees at Target Ovarian Cancer, said:
I am thrilled to be joined by Saswati, Jo and Angie as our newest trustees. It is truly a momentous time to join the Board of Target Ovarian Cancer as we embark on our new business plan Ovarian Cancer: Fast Forward. There is still much to do to achieve our goals, and accelerate progress for those living with ovarian cancer, and I have no doubt that their diverse skills, fresh perspectives and tireless enthusiasm will help us to harness new opportunities and build on the momentum from our recent successes.
Chief Executive at Target Ovarian Cancer, Annwen Jones OBE, said:
I am very pleased to welcome three highly qualified and committed leaders to our Board of Trustees . Angie, Jo and Saswati bring a wealth of experience and expertise across digital innovation, health and finance that will help us to fast forward life-saving progress for everyone impacted by ovarian cancer. These high-calibre appointments would not have been possible without the incredible support of The MBS Group, for which we are deeply grateful.
